µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype Na
Cys frameworks
disulfide-rich peptides
structure-activity relationships
voltage-gated sodium channels
µ-conotoxins
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
30 08 2022
30 08 2022
Historique:
received:
15
07
2022
revised:
25
08
2022
accepted:
26
08
2022
entrez:
22
9
2022
pubmed:
23
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
µ-Conotoxins are small, potent, peptide voltage-gated sodium (Na
Identifiants
pubmed: 36136538
pii: toxins14090600
doi: 10.3390/toxins14090600
pmc: PMC9506549
pii:
doi:
Substances chimiques
Analgesics
0
Conotoxins
0
NAV1.4 Voltage-Gated Sodium Channel
0
NAV1.7 Voltage-Gated Sodium Channel
0
Peptides
0
Voltage-Gated Sodium Channel Blockers
0
Cysteine
K848JZ4886
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : ZIABS012003
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC012003
Pays : United States
Références
ACS Omega. 2018 Oct 31;3(10):12330-12340
pubmed: 30411002
Biochemistry. 2012 Dec 11;51(49):9826-35
pubmed: 23167564
Cell Mol Life Sci. 2010 Jan;67(1):17-27
pubmed: 19705062
Chem Biol. 2007 Apr;14(4):399-407
pubmed: 17462575
J Med Chem. 2011 Nov 10;54(21):7558-66
pubmed: 21962108
J Biomol NMR. 1995 Jan;5(1):67-81
pubmed: 7881273
Biochem Pharmacol. 2021 Jan;183:114291
pubmed: 33075312
J Biol Chem. 2007 Oct 19;282(42):30699-706
pubmed: 17724025
Mol Pharmacol. 2007 Mar;71(3):676-85
pubmed: 17142296
Peptides. 2014 Mar;53:300-6
pubmed: 23871692
J Biol Chem. 1991 Sep 15;266(26):16989-91
pubmed: 1654319
FASEB J. 2019 Mar;33(3):3693-3703
pubmed: 30509130
J Biol Chem. 2012 Sep 7;287(37):31382-92
pubmed: 22773842
Br J Pharmacol. 2012 Jul;166(5):1654-68
pubmed: 22229737
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4892-5
pubmed: 23891024
J Biol Chem. 2003 Mar 7;278(10):8717-24
pubmed: 12471026
Mol Pharmacol. 2011 Oct;80(4):573-84
pubmed: 21709136
Br J Pharmacol. 2013 Apr;168(7):1597-610
pubmed: 23146020
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10302-7
pubmed: 21652775
Br J Pharmacol. 2012 Oct;167(3):576-86
pubmed: 22537004
Neuropharmacology. 2011 Jul-Aug;61(1-2):105-11
pubmed: 21419143
Pharmacol Ther. 2017 Apr;172:73-100
pubmed: 27916648
Biomedicines. 2020 Oct 02;8(10):
pubmed: 33023152
J Gen Physiol. 2002 Jan;119(1):45-54
pubmed: 11773237
J Biol Chem. 2003 Nov 21;278(47):46805-13
pubmed: 12970353
Angew Chem Int Ed Engl. 2014 Mar 10;53(11):2931-4
pubmed: 24604812
Biochemistry. 2002 Dec 24;41(51):15388-93
pubmed: 12484778
J Biol Chem. 2008 Aug 1;283(31):21621-8
pubmed: 18522941
Molecules. 2018 Oct 22;23(10):
pubmed: 30360356
Brain Behav Evol. 2015 Sep;86(1):58-74
pubmed: 26397110
J Biol Chem. 2022 Mar;298(3):101728
pubmed: 35167877
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1135-1140
pubmed: 27916464
FEBS J. 2011 Sep;278(18):3408-18
pubmed: 21781281
Bioconjug Chem. 2020 Jan 15;31(1):64-73
pubmed: 31790574
Biochemistry. 2009 Feb 17;48(6):1210-9
pubmed: 19170536
Science. 2019 Mar 22;363(6433):1309-1313
pubmed: 30765605
Annu Rev Neurosci. 2019 Jul 8;42:87-106
pubmed: 30702961